Status:

UNKNOWN

Vonoprazan Hp Dual or Triple Eradication Regimes

Lead Sponsor:

Xijing Hospital of Digestive Diseases

Conditions:

Helicobacter Pylori

Eligibility:

All Genders

18-70 years

Phase:

PHASE4

Brief Summary

To evaluate the efficacy and safety of dual or triple regimes for Helicobacter Pylori eradication using Vonoprazan as the antiacid agent.

Eligibility Criteria

Inclusion

  • Age 18 to 70 years old, both gender is eligiable;
  • Patients with definite Helicobacter Pylori infection (13C/14C urea breath test, rapid urease test and fecal Helicobacter Pylori antigen test positive) ;
  • Voluntary to accept Helicobacter Pylori eradication treatment;
  • Females of childbearing age are required to use medically acceptable contraceptive methods during the trial and within 30 days after the trial.

Exclusion

  • Patients with contraindications to the study drug or allergic to the study drug;
  • Severe organ damage and complications (such as liver cirrhosis, uremia, etc.), severe or unstable cardiopulmonary or endocrine diseases;
  • Continuous use of anti-ulcer drugs, antibiotics or bismuth complexes (at least 2 weeks before the examination for Helicobacter Pylori infection);
  • Pregnant and lactating women;
  • Have received upper gastrointestinal surgery;
  • Symptoms of dysphagia;
  • Evidence of bleeding or iron deficiency anemia;
  • have a history of malignant tumor;
  • History of drug or alcohol abuse within the past 1 year;
  • Systemic application of glucocorticoids, non-steroidal anti-inflammatory drugs, anticoagulants, and platelet aggregation inhibitors (except aspirin ≤100 mg/d);
  • Persons with mental disorders;
  • Received other clinical trials within the past 3 months;
  • Refused to sign the informed consent.

Key Trial Info

Start Date :

April 25 2022

Trial Type :

INTERVENTIONAL

Allocation :

ESTIMATED

End Date :

March 31 2023

Estimated Enrollment :

500 Patients enrolled

Trial Details

Trial ID

NCT05345210

Start Date

April 25 2022

End Date

March 31 2023

Last Update

October 20 2022

Active Locations (1)

Enter a location and click search to find clinical trials sorted by distance.

Page 1 of 1 (1 locations)

1

Xijing Hosipital of Digestive Disease

Xi'an, Shaanxi, China, 710032